-
1
-
-
0034471796
-
Molecular mechanisms of tumor angiogenesis and tumor progression
-
DOI 10.1023/A:1006414621286
-
Cavallaro U, Christofori G,. Molecular mechanisms of tumor angiogenesis and tumor progression. J Neurooncol 2000; 50: 63-70. (Pubitemid 32166291)
-
(2000)
Journal of Neuro-Oncology
, vol.50
, Issue.1-2
, pp. 63-70
-
-
Cavallaro, U.1
Christofori, G.2
-
2
-
-
39149110961
-
Tumor angiogenesis - A potential target in cancer chemoprevention
-
DOI 10.1016/j.fct.2007.08.032, PII S0278691507003237
-
Bhat TA, Singh RP,. Tumor angiogenesis-a potential target in cancer chemoprevention. Food Chem Toxicol 2008; 46: 1334-45. (Pubitemid 351258200)
-
(2008)
Food and Chemical Toxicology
, vol.46
, Issue.4
, pp. 1334-1345
-
-
Bhat, T.A.1
Singh, R.P.2
-
3
-
-
0034499732
-
Vascular endothelial growth factor and the regulation of angiogenesis
-
discussion- 6.
-
Ferrara N,. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 2000; 55: 15-35; discussion- 6.
-
(2000)
Recent Prog Horm Res
, vol.55
, pp. 15-35
-
-
Ferrara, N.1
-
4
-
-
58149122747
-
Activated STAT3 is a mediator and biomarker of VEGF endothelial activation
-
Chen SH, Murphy DA, Lassoued W, Thurston G, Feldman MD, Lee WM,. Activated STAT3 is a mediator and biomarker of VEGF endothelial activation. Cancer Biol Ther 2008; 7: 1994-2003.
-
(2008)
Cancer Biol Ther
, vol.7
, pp. 1994-2003
-
-
Chen, S.H.1
Murphy, D.A.2
Lassoued, W.3
Thurston, G.4
Feldman, M.D.5
Lee, W.M.6
-
5
-
-
39549102220
-
STAT3: A critical transcription activator in angiogenesis
-
DOI 10.1002/med.20101
-
Chen Z, Han ZC,. STAT3: a critical transcription activator in angiogenesis. Med Res Rev 2008; 28: 185-200. (Pubitemid 351281185)
-
(2008)
Medicinal Research Reviews
, vol.28
, Issue.2
, pp. 185-200
-
-
Chen, Z.1
Zhong, C.H.2
-
6
-
-
0037358192
-
3 requirement for VEGFR2-mediated activation of SAPK2/p38 and for Hsp90-dependent phosphorylation of focal adhesion kinase in endothelial cells activated by VEGF
-
DOI 10.1379/1466-1268(2003)8<37:IVRFVA>2.0.CO;2
-
Masson-Gadais B, Houle F, Laferriere J, Huot J,. Integrin alphavbeta3, requirement for VEGFR2-mediated activation of SAPK2/p38 and for Hsp90-dependent phosphorylation of focal adhesion kinase in endothelial cells activated by VEGF. Cell Stress Chaperones 2003; 8: 37-52. (Pubitemid 36444089)
-
(2003)
Cell Stress and Chaperones
, vol.8
, Issue.1
, pp. 37-52
-
-
Masson-Gadais, B.1
Houle, F.2
Laferriere, J.3
Huot, J.4
-
7
-
-
34548443831
-
Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibition
-
DOI 10.1016/j.cellsig.2007.05.013, PII S0898656807001532
-
Holmes K, Roberts OL, Thomas AM, Cross MJ,. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007; 19: 2003-12. (Pubitemid 47354167)
-
(2007)
Cellular Signalling
, vol.19
, Issue.10
, pp. 2003-2012
-
-
Holmes, K.1
Roberts, O.L.2
Thomas, A.M.3
Cross, M.J.4
-
8
-
-
40249116837
-
Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin
-
DOI 10.1038/ncb1695, PII NCB1695
-
Kitamura T, Asai N, Enomoto A, Maeda K, Kato T, Ishida M, Jiang P, Watanabe T, Usukura J, Kondo T, Costantini F, Murohara T, et al. Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin. Nat Cell Biol 2008; 10: 329-37. (Pubitemid 351331020)
-
(2008)
Nature Cell Biology
, vol.10
, Issue.3
, pp. 329-337
-
-
Kitamura, T.1
Asai, N.2
Enomoto, A.3
Maeda, K.4
Kato, T.5
Ishida, M.6
Jiang, P.7
Watanabe, T.8
Usukura, J.9
Kondo, T.10
Costantini, F.11
Murohara, T.12
Takahashi, M.13
-
9
-
-
77953022206
-
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
-
Sawamiphak S, Seidel S, Essmann CL, Wilkinson GA, Pitulescu ME, Acker T, Acker-Palmer A,. Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature 2010; 465: 487-91.
-
(2010)
Nature
, vol.465
, pp. 487-491
-
-
Sawamiphak, S.1
Seidel, S.2
Essmann, C.L.3
Wilkinson, G.A.4
Pitulescu, M.E.5
Acker, T.6
Acker-Palmer, A.7
-
10
-
-
77952884036
-
Selective targeting of adenovirus to alphavbeta3 integrins, VEGFR2 and Tie2 endothelial receptors by angio-adenobodies
-
Haisma HJ, Kamps GK, Bouma A, Geel TM, Rots MG, Kariath A, Bellu AR,. Selective targeting of adenovirus to alphavbeta3 integrins, VEGFR2 and Tie2 endothelial receptors by angio-adenobodies. Int J Pharm 2010; 391: 155-61.
-
(2010)
Int J Pharm
, vol.391
, pp. 155-161
-
-
Haisma, H.J.1
Kamps, G.K.2
Bouma, A.3
Geel, T.M.4
Rots, M.G.5
Kariath, A.6
Bellu, A.R.7
-
11
-
-
76649137259
-
Herbal compound farnesiferol C exerts antiangiogenic and antitumor activity and targets multiple aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) signaling cascades
-
Lee JH, Choi S, Lee Y, Lee HJ, Kim KH, Ahn KS, Bae H, Lee EO, Ryu SY, Lu J, Kim SH,. Herbal compound farnesiferol C exerts antiangiogenic and antitumor activity and targets multiple aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) signaling cascades. Mol Cancer Ther 2010; 9: 389-99.
-
(2010)
Mol Cancer Ther
, vol.9
, pp. 389-399
-
-
Lee, J.H.1
Choi, S.2
Lee, Y.3
Lee, H.J.4
Kim, K.H.5
Ahn, K.S.6
Bae, H.7
Lee, E.O.8
Ryu, S.Y.9
Lu, J.10
Kim, S.H.11
-
12
-
-
0037435011
-
Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
-
Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, Lee CN, Hsieh CY,. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 2003; 22: 1517-27.
-
(2003)
Oncogene
, vol.22
, pp. 1517-1527
-
-
Wei, L.H.1
Kuo, M.L.2
Chen, C.A.3
Chou, C.H.4
Lai, K.B.5
Lee, C.N.6
Hsieh, C.Y.7
-
13
-
-
33845190703
-
LC-APCI-MS method for detection and analysis of tryptanthrin, indigo, and indirubin in daqingye and banlangen
-
Liau BC, Jong TT, Lee MR, Chen SS,. LC-APCI-MS method for detection and analysis of tryptanthrin, indigo, and indirubin in daqingye and banlangen. J Pharm Biomed Anal 2007; 43: 346-51.
-
(2007)
J Pharm Biomed Anal
, vol.43
, pp. 346-351
-
-
Liau, B.C.1
Jong, T.T.2
Lee, M.R.3
Chen, S.S.4
-
14
-
-
20944435625
-
Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells
-
DOI 10.1073/pnas.0409467102
-
Nam S, Buettner R, Turkson J, Kim D, Cheng JQ, Muehlbeyer S, Hippe F, Vatter S, Merz KH, Eisenbrand G, Jove R,. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. Proc Natl Acad Sci USA 2005; 102: 5998-6003. (Pubitemid 40594244)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.17
, pp. 5998-6003
-
-
Nam, S.1
Buettner, R.2
Turkson, J.3
Kim, D.4
Cheng, J.Q.5
Muehlbeyer, S.6
Hippe, F.7
Vatter, S.8
Merz, K.-H.9
Eisenbrand, G.10
Jove, R.11
-
16
-
-
68149161142
-
Anti-tumor activity of noble indirubin derivatives in human solid tumor models in vitro
-
Kim SH, Choi SJ, Kim YC, Kuh HJ,. Anti-tumor activity of noble indirubin derivatives in human solid tumor models in vitro. Arch Pharm Res 2009; 32: 915-22.
-
(2009)
Arch Pharm Res
, vol.32
, pp. 915-922
-
-
Kim, S.H.1
Choi, S.J.2
Kim, Y.C.3
Kuh, H.J.4
-
17
-
-
0034694780
-
Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity
-
DOI 10.1016/S0014-2999(00)00879-7, PII S0014299900008797
-
Kunikata T, Tatefuji T, Aga H, Iwaki K, Ikeda M, Kurimoto M,. Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity. Eur J Pharmacol 2000; 410: 93-100. (Pubitemid 32008134)
-
(2000)
European Journal of Pharmacology
, vol.410
, Issue.1
, pp. 93-100
-
-
Kunikata, T.1
Tatefuji, T.2
Aga, H.3
Iwaki, K.4
Ikeda, M.5
Kurimoto, M.6
-
18
-
-
77956268307
-
Indirubin shows anti-angiogenic activity in an in vivo zebrafish model and an in vitro HUVEC model
-
Alex D, Lam IK, Lin Z, Lee SM,. Indirubin shows anti-angiogenic activity in an in vivo zebrafish model and an in vitro HUVEC model. J Ethnopharmacol 2010; 131: 242-7.
-
(2010)
J Ethnopharmacol
, vol.131
, pp. 242-247
-
-
Alex, D.1
Lam, I.K.2
Lin, Z.3
Lee, S.M.4
-
19
-
-
34249822498
-
Genes that Distinguish Physiological and Pathological Angiogenesis
-
DOI 10.1016/j.ccr.2007.04.017, PII S1535610807001444
-
Seaman S, Stevens J, Yang MY, Logsdon D, Graff-Cherry C, St Croix B,. Genes that distinguish physiological and pathological angiogenesis. Cancer Cell 2007; 11: 539-54. (Pubitemid 46856908)
-
(2007)
Cancer Cell
, vol.11
, Issue.6
, pp. 539-554
-
-
Seaman, S.1
Stevens, J.2
Yang, M.Y.3
Logsdon, D.4
Graff-Cherry, C.5
St. Croix, B.6
-
20
-
-
34147220392
-
Mediators of vascular remodelling co-opted for sequential steps in lung metastasis
-
DOI 10.1038/nature05760, PII NATURE05760
-
Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C, Gomis RR, Manova-Todorova K, Massague J,. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 2007; 446: 765-70. (Pubitemid 46582040)
-
(2007)
Nature
, vol.446
, Issue.7137
, pp. 765-770
-
-
Gupta, G.P.1
Nguyen, D.X.2
Chiang, A.C.3
Bos, P.D.4
Kim, J.Y.5
Nadal, C.6
Gomis, R.R.7
Manova-Todorova, K.8
Massague, J.9
-
21
-
-
1442354888
-
Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis
-
DOI 10.1073/pnas.0308671100
-
Brakenhielm E, Veitonmaki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B, Funahashi T, Cao Y,. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA 2004; 101: 2476-81. (Pubitemid 38269336)
-
(2004)
Proceedings of the National Academy of Sciences of the United States of America
, vol.101
, Issue.8
, pp. 2476-2481
-
-
Brakenhielm, E.1
Veitonmaki, N.2
Cao, R.3
Kihara, S.4
Matsuzawa, Y.5
Zhivotovsky, B.6
Funahashi, T.7
Cao, Y.8
-
22
-
-
58149473461
-
A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c-Src phosphorylation in VEGF-induced human umbilical endothelial cells
-
Yi ZF, Cho SG, Zhao H, Wu YY, Luo J, Li D, Yi T, Xu X, Wu Z, Liu M,. A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c-Src phosphorylation in VEGF-induced human umbilical endothelial cells. Int J Cancer 2009; 124: 843-52.
-
(2009)
Int J Cancer
, vol.124
, pp. 843-852
-
-
Yi, Z.F.1
Cho, S.G.2
Zhao, H.3
Wu, Y.Y.4
Luo, J.5
Li, D.6
Yi, T.7
Xu, X.8
Wu, Z.9
Liu, M.10
-
23
-
-
0034651013
-
Domain 5 of high molecular weight kininogen (kininostatin) down- regulates endothelial cell proliferation and migration and inhibits angiogenesis
-
Colman RW, Jameson BA, Lin Y, Johnson D, Mousa SA,. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis. Blood 2000; 95: 543-50. (Pubitemid 30041667)
-
(2000)
Blood
, vol.95
, Issue.2
, pp. 543-550
-
-
Colman, R.W.1
Jameson, B.A.2
Lin, Y.3
Johnson, D.4
Mousa, S.A.5
-
24
-
-
0029739615
-
A model of angiogenesis in the mouse cornea
-
Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato RJ,. A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci 1996; 37: 1625-32. (Pubitemid 26271414)
-
(1996)
Investigative Ophthalmology and Visual Science
, vol.37
, Issue.8
, pp. 1625-1632
-
-
Kenyon, B.M.1
Voest, E.E.2
Chen, C.C.3
Flynn, E.4
Folkman, J.5
D'Amato, R.J.6
-
25
-
-
40949101023
-
Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling
-
DOI 10.1158/0008-5472.CAN-07-5944
-
Yi T, Yi Z, Cho SG, Luo J, Pandey MK, Aggarwal BB, Liu M,. Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. Cancer Res 2008; 68: 1843-50. (Pubitemid 351416570)
-
(2008)
Cancer Research
, vol.68
, Issue.6
, pp. 1843-1850
-
-
Yi, T.1
Yi, Z.2
Cho, S.-G.3
Luo, J.4
Pandey, M.K.5
Aggarwal, B.B.6
Liu, M.7
-
26
-
-
51049120763
-
Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways
-
Yi T, Cho SG, Yi Z, Pang X, Rodriguez M, Wang Y, Sethi G, Aggarwal BB, Liu M,. Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Mol Cancer Ther 2008; 7: 1789-96.
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 1789-1796
-
-
Yi, T.1
Cho, S.G.2
Yi, Z.3
Pang, X.4
Rodriguez, M.5
Wang, Y.6
Sethi, G.7
Aggarwal, B.B.8
Liu, M.9
-
27
-
-
0344958751
-
TWEAK induces angiogenesis and proliferation of endothelial cells
-
DOI 10.1074/jbc.274.13.8455
-
Lynch CN, Wang YC, Lund JK, Chen YW, Leal JA, Wiley SR,. TWEAK induces angiogenesis and proliferation of endothelial cells. J Biol Chem 1999; 274: 8455-9. (Pubitemid 29164634)
-
(1999)
Journal of Biological Chemistry
, vol.274
, Issue.13
, pp. 8455-8459
-
-
Lynch, C.N.1
Wang, Y.C.2
Lund, J.K.3
Chen, Y.-W.4
Leal, J.A.5
Wiley, S.R.6
-
28
-
-
0030447816
-
The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis
-
Ribatti D, Vacca A, Roncali L, Dammacco F,. The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. Int J Dev Biol 1996; 40: 1189-97. (Pubitemid 27072813)
-
(1996)
International Journal of Developmental Biology
, vol.40
, Issue.6
, pp. 1189-1197
-
-
Ribatti, D.1
Vacca, A.2
Roncali, L.3
Dammacco, F.4
-
29
-
-
39549101635
-
Drug modification of angiogenesis in a rat cornea model
-
Schwartz S, George J, Ben-Shoshan J, Luboshits G, Avni I, Levkovitch-Verbin H, Ziv H, Rosner M, Barak A,. Drug modification of angiogenesis in a rat cornea model. Invest Ophthalmol Vis Sci 2008; 49: 250-4.
-
(2008)
Invest Ophthalmol Vis Sci
, vol.49
, pp. 250-254
-
-
Schwartz, S.1
George, J.2
Ben-Shoshan, J.3
Luboshits, G.4
Avni, I.5
Levkovitch-Verbin, H.6
Ziv, H.7
Rosner, M.8
Barak, A.9
-
30
-
-
0026478824
-
Effects of nicardipine on tube formation of bovine vascular endothelial cells in vitro
-
Kaneko T, Nagata I, Miyamoto S, Kubo H, Kikuchi H, Fujisato T, Ikada Y,. Effects of nicardipine on tube formation of bovine vascular endothelial cells in vitro. Stroke 1992; 23: 1637-42.
-
(1992)
Stroke
, vol.23
, pp. 1637-1642
-
-
Kaneko, T.1
Nagata, I.2
Miyamoto, S.3
Kubo, H.4
Kikuchi, H.5
Fujisato, T.6
Ikada, Y.7
-
31
-
-
2442688305
-
Regulation of endothelial cell function by FAK and Pyk2
-
d1000-1499
-
Orr AW, Murphy-Ullrich JE,. Regulation of endothelial cell function BY FAK and PYK2. Front Biosci 2004; 9: 1254-66. (Pubitemid 39060841)
-
(2004)
Frontiers in Bioscience
, vol.9
, pp. 1254-1266
-
-
Orr, A.W.1
Murphy-Ullrich, J.E.2
-
32
-
-
39149099155
-
Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo
-
DOI 10.1158/0008-5472.CAN-07-5311
-
Huang D, Ding Y, Luo WM, Bender S, Qian CN, Kort E, Zhang ZF, VandenBeldt K, Duesbery NS, Resau JH, Teh BT,. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo. Cancer Res 2008; 68: 81-8. (Pubitemid 351380108)
-
(2008)
Cancer Research
, vol.68
, Issue.1
, pp. 81-88
-
-
Huang, D.1
Ding, Y.2
Luo, W.-M.3
Bender, S.4
Qian, C.-N.5
Kort, E.6
Zhang, Z.-F.7
VandenBeldt, K.8
Duesbery, N.S.9
Resau, J.H.10
Bin, T.T.11
-
33
-
-
34347388883
-
Inhibition of P38 MAPK reduces tumor conditioned medium-induced angiogenesis in co-cultured human umbilical vein endothelial cells and fibroblasts
-
DOI 10.1271/bbb.60617
-
Ye J, Yuan L,. Inhibition of p38 MAPK reduces tumor conditioned medium-induced angiogenesis in co-cultured human umbilical vein endothelial cells and fibroblasts. Biosci Biotechnol Biochem 2007; 71: 1162-9. (Pubitemid 47164232)
-
(2007)
Bioscience, Biotechnology and Biochemistry
, vol.71
, Issue.5
, pp. 1162-1169
-
-
Ye, J.1
Yuan, L.2
-
34
-
-
73349112557
-
Degarelix 240/80 mg: A new treatment option for patients with advanced prostate cancer
-
Boccon-Gibod L, Iversen P, Persson BE,. Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer. Expert Rev Anticancer Ther 2009; 9: 1737-43.
-
(2009)
Expert Rev Anticancer Ther
, vol.9
, pp. 1737-1743
-
-
Boccon-Gibod, L.1
Iversen, P.2
Persson, B.E.3
-
36
-
-
33646107369
-
VEGF receptor signalling-in control of vascular function
-
Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L,. VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol 2006; 7: 359-71.
-
(2006)
Nat Rev Mol Cell Biol
, vol.7
, pp. 359-371
-
-
Olsson, A.K.1
Dimberg, A.2
Kreuger, J.3
Claesson-Welsh, L.4
-
37
-
-
16444380479
-
KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway
-
DOI 10.1038/sj.onc.1208442
-
Burger M, Hartmann T, Burger JA, Schraufstatter I,. KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway. Oncogene 2005; 24: 2067-75. (Pubitemid 40516200)
-
(2005)
Oncogene
, vol.24
, Issue.12
, pp. 2067-2075
-
-
Burger, M.1
Hartmann, T.2
Burger, J.A.3
Schraufstatter, I.4
-
38
-
-
0242285719
-
STAT proteins: From normal control of cellular events to tumorigenesis
-
DOI 10.1002/jcp.10364
-
Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A,. STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 2003; 197: 157-68. (Pubitemid 37485244)
-
(2003)
Journal of Cellular Physiology
, vol.197
, Issue.2
, pp. 157-168
-
-
Calo, V.1
Migliavacca, M.2
Bazan, V.3
Macaluso, M.4
Buscemi, M.5
Gebbia, N.6
Russo, A.7
-
39
-
-
0141960055
-
Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation
-
DOI 10.1074/jbc.M301866200
-
Yahata Y, Shirakata Y, Tokumaru S, Yamasaki K, Sayama K, Hanakawa Y, Detmar M, Hashimoto K,. Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation. J Biol Chem 2003; 278: 40026-31. (Pubitemid 37248568)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.41
, pp. 40026-40031
-
-
Yahata, Y.1
Shirakata, Y.2
Tokumaru, S.3
Yamasaki, K.4
Sayama, K.5
Hanakawa, Y.6
Detmar, M.7
Hashimoto, K.8
-
40
-
-
0042704747
-
VEGF differentially activates STAT3 in microvascular endothelial cells
-
Bartoli M, Platt D, Lemtalsi T, Gu X, Brooks SE, Marrero MB, Caldwell RB,. VEGF differentially activates STAT3 in microvascular endothelial cells. FASEB J 2003; 17: 1562-4.
-
(2003)
FASEB J
, vol.17
, pp. 1562-1564
-
-
Bartoli, M.1
Platt, D.2
Lemtalsi, T.3
Gu, X.4
Brooks, S.E.5
Marrero, M.B.6
Caldwell, R.B.7
-
41
-
-
0037233190
-
Angiogenesis assays: A critical overview
-
DOI 10.1373/49.1.32
-
Auerbach R, Lewis R, Shinners B, Kubai L, Akhtar N,. Angiogenesis assays: a critical overview. Clin Chem 2003; 49: 32-40. (Pubitemid 36078551)
-
(2003)
Clinical Chemistry
, vol.49
, Issue.1
, pp. 32-40
-
-
Auerbach, R.1
Lewis, R.2
Shinners, B.3
Kubai, L.4
Akhtar, N.5
-
42
-
-
20444372636
-
Hypericin in the dark inhibits key steps of angiogenesis in vitro
-
DOI 10.1016/j.ejphar.2005.03.047, PII S0014299905003298
-
Martinez-Poveda B, Quesada AR, Medina MA,. Hypericin in the dark inhibits key steps of angiogenesis in vitro. Eur J Pharmacol 2005; 516: 97-103. (Pubitemid 40799344)
-
(2005)
European Journal of Pharmacology
, vol.516
, Issue.2
, pp. 97-103
-
-
Martinez-Poveda, B.1
Quesada, A.R.2
Medina, M.A.3
-
43
-
-
0036884617
-
Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin
-
Okamoto T, Yamagishi S, Inagaki Y, Amano S, Koga K, Abe R, Takeuchi M, Ohno S, Yoshimura A, Makita Z,. Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin. FASEB J 2002; 16: 1928-30.
-
(2002)
FASEB J
, vol.16
, pp. 1928-1930
-
-
Okamoto, T.1
Yamagishi, S.2
Inagaki, Y.3
Amano, S.4
Koga, K.5
Abe, R.6
Takeuchi, M.7
Ohno, S.8
Yoshimura, A.9
Makita, Z.10
|